{"id":2467,"date":"2017-04-01T12:05:00","date_gmt":"2017-04-01T10:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2017\/leserbrief-statin-myopathie-und-pcsk9-hemmer"},"modified":"2017-04-01T12:05:00","modified_gmt":"2017-04-01T10:05:00","slug":"leserbrief-statin-myopathie-und-pcsk9-hemmer","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2017\/leserbrief-statin-myopathie-und-pcsk9-hemmer","title":{"rendered":"Leserbrief: Statin-Myopathie und PCSK9-Hemmer"},"content":{"rendered":"<p>Frage von U.N. aus N.: >> Ich bin Arzt i.R. und habe selbst eine Statin-Myopathie ohne Erh\u00f6hung der Kreatinkinase (CK) mit Muskelschmerzen und -schw\u00e4che im Laufe einer 15-j\u00e4hrigen Statin-Therapie entwickelt. Vor 1,5 Jahren wurden die Statine schlie\u00dflich abgesetzt, und ich bekam Evolocumab. Danach kam es zu einer Reduktion der Muskelbeschwerden um nur 50%. Wie sch\u00e4tzen [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von U.N. aus N.: >> Ich bin Arzt i.R. und habe selbst eine Statin-Myopathie ohne Erh\u00f6hung der Kreatinkinase (CK) mit Muskelschmerzen und -schw\u00e4che im Laufe einer 15-j\u00e4hrigen Statin-Therapie entwickelt. Vor 1,5 Jahren wurden die Statine schlie\u00dflich abgesetzt, und ich bekam Evolocumab. Danach kam es zu einer Reduktion der Muskelbeschwerden um nur 50%. Wie sch\u00e4tzen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1274,451,449,3065,4869,4870,455,453,456,1525,1526,1522,443],"class_list":["post-2467","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-cholesterin","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-evolocumab","tag-fourier-studie","tag-gauss-studie","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-lipidsenker","tag-pcsk9","tag-pcsk9-antikoerper","tag-pcsk9-hemmer","tag-statine"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2467"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2467\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}